Company Technologies Markets Collaborations Investors Careers Contact Search Synthetic Biology Synthetic Biology is the engineering of biological systems to enable rational, design-based control of cellular function for a specific purpose. The programming of DNA and reformatting of genetic circuitry within cell platforms has created a paradigm shift whereby the analysis of biology is being supplanted by its synthesis. This advancement has the potential to significantly impact approaches relied upon for some time across a variety of industries. The ability to create and modify 'organic' materials on increasingly larger scales has occurred with a number of breakthroughs in genetic engineering including automated DNA sequencing, DNA synthesis, the advent of computational bioinformatics, and the creation of genetically modified organisms. Today, Intrexon's expertise in designing DNA and constructing complex gene programs utilizing a modular, scalable approach with an embedded capacity to predict the viability of a biological solution, places it at the leading-edge of this growing synthetic biology discipline. Company Synthetic Biology Our Platform Operating Units & Divisions Subsidiaries Management Board of Directors Our Commitment Company Synthetic Biology Our Platform Operating Units & Divisions Subsidiaries Management Board of Directors Our Commitment Technologies UltraVector® RheoSwitch® Cell Systems Informatics Protein Engineering AttSite® Recombinases LEAP® Antibody Discovery Neurospora & Agaricus Platforms Endometrial Regenerative Cells BeyondBio™ Scientific Literature Markets Health Food Energy Environment Consumer Collaborations Exclusive Channel Collaborations Joint Ventures Intrexon Institute for Biomolecular Research Partnering Opportunities Investors Press Releases Stock Information Corporate Governance SEC Filings Events/Conferences Investors Packet FAQ Information Request IRS Form 8937 Careers Contact Legal Notices © 2015 Intrexon